Remove topic cardiovascular-disease
article thumbnail

Nine for 2024, Pt 1: From fragility to resilience

pharmaphorum

In this thought leadership piece by IQVIA EMEA, explore the topic of cardiovascular disease and the strategies needed to shift from fragility to resilience.

63
article thumbnail

Glaucoma

RX Note

Other risk factors include advancing age, family history, ethnicity, corticosteroid use, myopia, type 2 diabetes mellitus , cardiovascular disease and hypertension. Initial treatment of glaucoma is generally with topical drugs; selective laser trabeculoplasty may be considered in some patients.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding the prevention and treatment needs for cardiovascular disease

pharmaphorum

What does the current picture of cardiovascular disease in Europe look like? Surprisingly for many, cardiovascular disease (CVD) is Europe’s leading cause of death – not cancer, as many people would assume. The post Understanding the prevention and treatment needs for cardiovascular disease appeared first on.

article thumbnail

Gatehouse Bio and AstraZeneca to develop RNA therapeutics for heart failure

Pharmaceutical Technology

Initially, the companies partnered to identify new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s artificial intelligence (AI)-powered platform in December 2019. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

Health Innovators: Sidekick Health’s Saemundur “Sam” Oddsson

pharmaphorum

Watch the video below to hear more on those topics and to find out more about Sidekick Health, its solution and partnerships, plus Sam’s personal advice for budding entrepreneurs. He is also an accomplished researcher and author of several peer-reviewed articles in the areas of obesity, cardiovascular disease and lung disease.

article thumbnail

How Do You Become an Anesthesiologist?  

Board Vitals - Pharmacist

The following topics are on the USMLE Step 1 : . Maintenance/Disease Prevention: 8-12% Pharmacotherapy: 8-12% Clinical Interventions: 6-10% Mixed Management: 12-16% . Advanced Topics in Anesthesiology 50%. The ABA ADVANCED Exam consists of 200 multiple choice questions that cover the following topics: .

article thumbnail

Rocket agrees to acquire biotech firm Renovacor

Pharmaceutical Technology

Renovacor focuses on offering precision treatments for genetic cardiovascular and mechanistically-related ailments. Building on our success in Danon Disease to date, I am particularly excited to expand our cardiology focus and capabilities and address a clear unmet medical need in BAG3-associated dilated cardiomyopathy. for each share.

59